Technical analysis of Cocrystal Pharma, Inc. (COCP): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, and noroviruses.
Price Performance
| 1 month | +5.56% |
| 3 months | +14.57% |
| Year-to-date | +16.45% |
| 1 year | -6.56% |
| 3 years | -43.84% |
| 5 years | -90.95% |
52-Week Range
| 52-week High | $2.03 |
| 52-week Low | $0.76 |
| Avg Volume (90d) | 78K |
Technical Indicators
| SMA 50 | $1.05 |
| SMA 200 | $1.10 |
| Beta | 1.18 |
| 30-day Volatility (annualised) | 47.8% |
| Price vs SMA 50 | +8.4% |
| Price vs SMA 200 | +4.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.09 | |
| 2025-11 | $1.06 | -2.8% |
| 2025-12 | $0.98 | -7.6% |
| 2026-01 | $0.98 | +0.1% |
| 2026-02 | $1.05 | +7.1% |
| 2026-03 | $1.01 | -3.8% |
| 2026-04 | $1.43 | +41.6% |
| 2026-05 | $1.12 | -21.7% |
| 2026-06 | $1.05 | -6.3% |
| 2026-07 | $0.82 | -21.9% |
| 2026-08 | $1.16 | +41.5% |
| 2026-09 | $1.14 | -1.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $1.14 |
| Market Cap | $16M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 14.67 |
| EV / EBITDA | -1.55 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 1.28 |
| Current Ratio | 1.24 |